Patricia Randall has become vice president, general counsel, and chief legal officer of Matritech. Prior to joining Matritech, she was vice president and general counsel of
Robotic Vision Systems
. Before that, she was vice president and general counsel of the electronic interconnect product manufacturer Hadco. Randall also previously taught at Northeastern University School of Law and at Harvard Law School. She holds a JD from Northeastern University School of Law and a BA from American University.
Patricia Schreck has become executive vice president and general counsel of Incyte. Schreck was previously chief patent counsel at Elan Drug Delivery. She has also served as general counsel for diaDexus, a joint venture between Incyte and GlaxoSmithKline. Before that she worked at GSK in patent roles. Schreck will replace Lee Bendekgey, who was general counsel as well as general manager of the information products group for Incyte.
Charles Cantor has joined the scientific advisory board of Michigan-based GeneGo. Cantor is currently chief scientific officer and a board director of Sequenom. He is also director of the Center for Advanced Biotechnology at Boston University. Cantor was previously the director of the Human Genome Center of the Department of Energy at Lawrence Berkeley Laboratory. He founded Selectx Pharmaceuticals in 2002.
Cheri Walker has been appointed vice president, corporate development and Mark Gardner has been appointed vice president of process improvement at Invitrogen.
Walker comes to Invitrogen from Deutsche Bank, where she was vice president, North American equity research.
Gardner is a Six Sigma Master Black Belt — which means that he has completed a special program on best practices in management. His prior experience includes six sigma and acquisition integration at the IT division of General Electric Medical Systems. Before joining GE, he was a consultant at McKinsey & Company and a lieutenant commander and pilot in the United States Navy.